Target intelligence / Profile preview

ETS variant transcription factor 3 (ETV3)

Target
ETV3
Molecular classification
Transcription factor, ETS family, ETS domain-containing protein, Transcriptional repressor
01

Overview

ETS variant transcription factor 3 (ETV3) is a member of the ETS family of transcription factors, characterized by a conserved ETS DNA-binding domain that recognizes core GGA(A/T) motifs in target DNA[1][4]. ETV3 acts primarily as a transcriptional repressor, modulating gene expression programs involved in cell growth, differentiation, and immune function. Specifically, ETV3 contributes to growth arrest during terminal macrophage differentiation by repressing genes downstream of Ras signaling and is also involved in the regulation of monocyte differentiation, particularly influencing the balance between macrophage and dendritic cell lineage outcomes[2][4]. Its action includes the repression of interferon-stimulated genes and direct inhibition of macrophage differentiation through suppression of MAFB expression. While ETV3 and its closely related factor ETV6 are molecular regulators of immune cell differentiation and have been proposed as potential modulators of inflammatory responses, there is currently no direct evidence supporting the use of drugs targeting ETV3 in clinical practice[2][4].

Other names
ETS translocation variant 3METSPE1PE-1Mitogenic Ets transcriptional suppressorETS domain transcriptional repressor PE1ets variant gene 3ETS family transcriptional repressor
02

Biological functions

Regulation of cell cycle arrestRepression of Ras-dependent gene expressionMonocyte differentiation and fate decisionInhibition of interferon-stimulated genesImmune cell differentiationControl of macrophage and dendritic cell lineage commitment
03

Disease associations

InflammationPotential roles in autoimmune disordersImmune regulationOther (very limited direct disease linkage; some mentions of possible anti-inflammatory function)

Beyond the preview

Go deeper on ETS variant transcription factor 3 (ETV3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ETS variant transcription factor 3 (ETV3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call